Mead Johnson Nutrition CO (MJN) : Tyrus Capital S.a.m. added new position in Mead Johnson Nutrition CO during the most recent quarter end. The investment management firm now holds 10,000 shares of Mead Johnson Nutrition CO which is valued at $889,500 , the company said in a statement filed on Aug 15, 2016 with the SEC.Mead Johnson Nutrition CO makes up approximately 0.28% of Tyrus Capital S.a.m.’s portfolio.
Other Hedge Funds, Including , Granite Investment Partners reduced its stake in MJN by selling 680 shares or 21.87% in the most recent quarter. The Hedge Fund company now holds 2,429 shares of MJN which is valued at $216,060. Mead Johnson Nutrition CO makes up approx 0.02% of Granite Investment Partners’s portfolio.Tcw Group Inc reduced its stake in MJN by selling 891 shares or 4.27% in the most recent quarter. The Hedge Fund company now holds 19,992 shares of MJN which is valued at $1,778,288. Mead Johnson Nutrition CO makes up approx 0.01% of Tcw Group Inc’s portfolio.Gamco Investors Et Al reduced its stake in MJN by selling 4,213 shares or 4.57% in the most recent quarter. The Hedge Fund company now holds 87,917 shares of MJN which is valued at $7,703,288. Mead Johnson Nutrition CO makes up approx 0.05% of Gamco Investors Et Al’s portfolio.Calvert Investment Management boosted its stake in MJN in the latest quarter, The investment management firm added 691 additional shares and now holds a total of 14,518 shares of Mead Johnson Nutrition CO which is valued at $1,272,067. Mead Johnson Nutrition CO makes up approx 0.06% of Calvert Investment Management’s portfolio. Kwmg added MJN to its portfolio by purchasing 3,761 company shares during the most recent quarter which is valued at $345,485. Mead Johnson Nutrition CO makes up approx 0.18% of Kwmg’s portfolio.
Mead Johnson Nutrition CO closed down -1.75 points or -2.06% at $83.32 with 17,73,221 shares getting traded on Thursday. Post opening the session at $84.6, the shares hit an intraday low of $82.73 and an intraday high of $84.71 and the price fluctuated in this range throughout the day.Shares ended Thursday session in Red.
On the company’s financial health, Mead Johnson Nutrition CO reported $0.88 EPS for the quarter, beating the analyst consensus estimate by $ 0.10 according to the earnings call on Jul 28, 2016. Analyst had a consensus of $0.78. The company had revenue of $941.50 million for the quarter, compared to analysts expectations of $963.64 million. The company’s revenue was down -8.8 % compared to the same quarter last year.During the same quarter in the previous year, the company posted $0.76 EPS.
Many Wall Street Analysts have commented on Mead Johnson Nutrition CO. CLSA Upgraded Mead Johnson Nutrition CO on Aug 3, 2016 to ” Outperform”, Price Target of the shares are set at $96.Mead Johnson Nutrition CO was Downgraded by Societe Generale to ” Hold” on Jul 29, 2016. Mead Johnson Nutrition CO was Upgraded by JP Morgan to ” Overweight” on Jul 26, 2016.
Mead Johnson Nutrition Company (Mead Johnson) is a global pediatric nutrition company. The Company manufactures distributes and sells infant formulas children’s nutrition and other nutritional products. Its product portfolio includes routine and specialty infant formulas childrens milks and milk modifiers dietary supplements for pregnant and breastfeeding mothers pediatric vitamins and products for pediatric metabolic disorders. The Company operates through three segments: Asia Latin America and North America/Europe. The Company’s Enfa family of brands including Enfamil infant formula is a brand franchise in pediatric nutrition. Its product portfolio addresses a range of nutritional needs for infants children and expectant and nursing mothers. The Company markets its portfolio of more than 70 products to mothers healthcare professionals and retailers in more than 50 countries in Asia North America Latin America and Europe.